DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.17, $0.02 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $696.2 million versus the consensus estimate of $700.45 million.

GUIDANCE:

DexCom sees Q3 2022 revenue of $2.86-2.91 billion, versus the consensus of $2.92 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.